Clinical Trials Logo

Nervous System Diseases clinical trials

View clinical trials related to Nervous System Diseases.

Filter by:

NCT ID: NCT03800537 Completed - Clinical trials for Disease;Neurological

MR Fingerprinting: A Novel Sequence Applied to Neuroimaging

Start date: March 8, 2019
Phase: N/A
Study type: Interventional

Magnetic Resonance Imaging (MRI) has become one of most important medical imaging tools over the past 30 years because it is non-invasive, requires no ionizing radiation, and provides exquisite images of soft tissues and anatomic structures with many tissue/disease specific contrasts. While MRI has served the community well for many years, it is increasingly clear that it also has significant limitations. One of the principle limitations is the lack of quantitative information for tissue/structure characterization. The current paradigm of MRI is to use a set of scanner settings to generate an image "weighted" by a specific MR contrast mechanism (physical parameter), where it is hoped that variations in the parameter will be accentuated. However, without quantitative knowledge of the parameters, the final image contrast may depend on many factors, which complicates image interpretation and diagnostic performance. Quantitative measurement can provide a great deal of information about tissue properties and pathological conditions, since these parameters ultimately determine the contrast that is observed in conventional images.

NCT ID: NCT03787199 Completed - Stroke Clinical Trials

Feasibility of the Overground Bodyweight Supporting Walking System Andago

Start date: May 28, 2018
Phase: N/A
Study type: Interventional

The overall aim of this project is to investigate the clinical utility of the Andago System, a CE certified mobile bodyweight supporting walking robot, in children with neuromotor disorders. Clinical utility encompasses practicability, acceptability, appropriateness, and accessibility. In this study, the investigators would like to investigate several aspects of clinical utility that belong to the first three components.

NCT ID: NCT03775538 Completed - Parkinson Disease Clinical Trials

Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study

Start date: July 5, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

This study is an extension to the HP-CD-CL-2002 clinical study. It evaluates the long-term safety and tolerability of CDNF in patients with Parkinson's disease when dosed directly into the brain using an implanted investigational drug delivery system (DDS). Long-term safety of the DDS is also being evaluated. All patients will receive monthly infusions of either mid- or high-dose of CDNF for a period of 6 months.

NCT ID: NCT03753841 Completed - Dysphagia Clinical Trials

FEES to Determine Neurological Intensive Care Patients' Oral Diet

Start date: January 14, 2014
Phase: N/A
Study type: Interventional

Dysphagia is associated with high rates of mortality and morbidity. Adjusting the oral diet of ICU-patients based on flexible endoscopic evaluation of swallowing (FEES) findings might reduce pneumonia rate, mortality and need for intubation/tracheotomy.

NCT ID: NCT03750188 Completed - Clinical trials for Central Nervous System Diseases

Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrs

Start date: November 1, 2018
Phase:
Study type: Observational

Safety and Efficacy Study in pediatric subjects <2 years of age who have undergone Brain or Spine MRI pre and post 0.1 mmol/kg ProHance administration. Imaging conditions will represent those in routine clinical practice. Retrospective enrolment with a prospective blinded read.

NCT ID: NCT03709407 Completed - Blood Pressure Clinical Trials

"Effects of Manual Lymphatic Drainage in the Neck in Healthy Subjects. Experimental Randomized Crossover Study"

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Drainage manoeuvres described in different Manual Lymphatic Drainage methods, suggest modificactions in vital signs, by changes at nervous system, that would involve modifications to heart rate, breathing rate, blood pressure, cardiac vascular level (arteries and lymphatics). In addition this hypothetical relaxing effect could be beneficial for other types of pathologies associated with the presence of stress, cardiac problems, respiratory pathology, muscle tension, muscle trigger points, etc. With this study investigators compare different manoeuvres in the neck area to observe the results in the participants regarding the basal state.

NCT ID: NCT03670459 Completed - Neurologic Disorder Clinical Trials

Forty Five Patients With Multiple Sclerosis Recieved Vestibular Rehabilitation and Balance Training

Start date: December 31, 2017
Phase: N/A
Study type: Interventional

Patients with multiple sclerosis (MS) might develop dizziness or vertigo as a first manifestation or during the course of the illness. Many patients with MS experience chronic or intermittent dizziness. Acute symptoms of dizziness or vertigo in MS fall into two categories; acute vestibular syndrome (AVS) and positional vertigo. Vestibular disorder due to MS decreases whole body dynamic postural control and causes many functional limitations as limitations in ambulation, dynamic balance and trunk control and that decreases the quality of life. Vestibular dysfunction has long been recognized as causing some of the most common symptoms in MS, true vertigo is found at presentation in up to 17% of patients, several recent reports have suggested that vestibular symptoms develop early in the disease process. Vestibular Rehabilitation has been shown to be effective in reducing symptoms and improving function for patients with vestibular disorders. The goal of vestibular rehabilitation is to promote the central nervous system compensation through exercise-based strategies.

NCT ID: NCT03662139 Completed - Cerebral Palsy Clinical Trials

Dynamic Gait Index in Hemiplegic Cerebral Palsy

Start date: April 1, 2018
Phase:
Study type: Observational

The purpose of this study is to assess validity and reliability of Dynamic Gait Index (DGI) in patients with unilateral spastic cerebral palsy

NCT ID: NCT03639909 Completed - Clinical trials for Neurological Disorder

Analysis of the Sweat Response According to the Pathology in Neurologic Patients

Sudoscan
Start date: March 2015
Phase:
Study type: Observational

Cardiovascular autonomic neuropathy (CAN) has been shown to be an important risk factor for cardiac diseases, particularly in diabetes. CAN may be investigated by a battery of laboratory cardiovascular autonomic reflex tests(initially described by Ewing). First screening for CAN (as proposed in diabetic patients) can be performed by assessing heart rate (HR) response to deep breathing, blood pressure (BP) and HR response to a 5 minutes stand test

NCT ID: NCT03626805 Completed - Migraine Disorders Clinical Trials

Muscle Tenderness and Hardness in Migraine Patients

Start date: August 13, 2017
Phase:
Study type: Observational

The aim of the study is to examine symptomatology, quantitative sensory test (QST) parameters, muscle tenderness and muscle hardness in migraine patients interictally and compare with healthy controls